CN Patent

CN115023223A — 用于治疗口服利尿剂难治性水肿的方法和组合物

Assigned to Resjoy Pharmaceuticals LLC · Expires 2022-09-06 · 4y expired

What this patent protects

本发明的特征在于用于鼻内、舌下和皮下施用布美他尼以治疗患有口服利尿剂难治性水肿的受试者的方法和组合物。

USPTO Abstract

本发明的特征在于用于鼻内、舌下和皮下施用布美他尼以治疗患有口服利尿剂难治性水肿的受试者的方法和组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN115023223A
Jurisdiction
CN
Classification
Expires
2022-09-06
Drug substance claim
No
Drug product claim
No
Assignee
Resjoy Pharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.